NFKB1 and glaucoma: Because our invitro studies have shown that rapamycin suppresses microglial activation by inhibiting NF-κB signaling, we next investigated whether this mechanism is also implicated in rapamycin–mediated neuroprotective effects in experimental glaucoma.